e-ISSN: 2394-2967
logo

British Journal of Medical and Health Research

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

📢 Latest Update: Call for Papers: Special Issue on Medical and Health Research – Submit to British Journal (BJMHR) by March 31, 2026

Volume 10, Issue 9 - 2023 (September 2023 Issue 9)

Volume 10 Issue 9 Cover

Issue Details:

Volume 10 Issue 9
Published:Invalid Date

Editorial: September 2023 Issue 9

Welcome to the 2023 issue of British Journal of Medical and Health Research. This issue showcases the remarkable breadth and depth of contemporary research across multiple disciplines. From cutting-edge applications of machine learning in climate science to the revolutionary potential of quantum computing in drug discovery, our featured articles demonstrate the power of interdisciplinary collaboration in addressing global challenges.

We are particularly excited to present research that bridges traditional academic boundaries, reflecting our journal's commitment to fostering innovation through cross-disciplinary dialogue. The integration of artificial intelligence with environmental science, the application of blockchain technology to supply chain management, and the convergence of urban planning with smart city technologies exemplify the transformative potential of collaborative research.

As we continue to navigate an era of rapid technological advancement and global challenges, the research presented in this issue offers both insights and solutions that will shape our future. We thank our authors, reviewers, and editorial board members for their continued dedication to advancing knowledge and promoting scientific excellence.

Dr Hemangi J Patel
Editor-in-Chief
British Journal of Medical and Health Research

Articles in This Issue

Showing 4 of 4 articles
Research PaperID: BJMHR1009001

Bilateral Renal Agenesis: About A Rare Case

Ilyass Baouch, Mustapha Hamdi, Dina Alami, houda Moustaide, Saad Benkirane

Renal agenesis is the absence of renal tissue due to defects in early embryonic development. It is often associated with other congenital abnormalities. The incidence of bilateral renal agenesis ranges from 0.1 to 0.3 per 1,000 births, making it a rare condition. Its diagnosis is mainly based on obstetric ultrasound by direct and indirect signs. Magnetic Resonance Imaging (MRI) has a higher sensitivity and specificity, and has its place when in doubt or when other anomalies are suspected. Management of bilateral renal agenesis relies primarily on prevention of pulmonary hypoplasia during pregnancy by amnioinfusion and correction of postpartum complications related to renal absence. Although the prognosis for bilateral renal agenesis is extremely poor and the risk of death in the neonatal period is high. We report a pregnancy in which prenatal ultrasound revealed anhydramnios and the absence of both fetal kidneys, To overcome the difficulties in obtaining accurate information on fetal ultrasound in cases of oligohydramnios, we used fetal magnetic resonance imaging (MRI) to confirm renal status, wich confirmed fetal renal agenesis and provided a more accurate diagnosis. The neonate was born with a complex dysmorphic syndrome and died 45 minutes after birth due to respiratory distress.

renal lodgeprenatal ultrasoundanydramniosisamnioinfusionmedical termination of pregnancypotter's syndrome.
57,629 views
17,252 downloads

Contributors:

 Ilyass Baouch
,
 Mustapha Hamdi
,
 Dina Alami
,
 houda Moustaide
,
 Saad Benkirane
Research PaperID: BJMHR1009002

EFFECT OF IRON DEFICIENCY ANEMIA (IDA) ON THYROID FUNCTION AND HAEMATOLOGICAL PROFILE IN PREGNANCY

Gurpreet Kaur Gill, Ankita Ohri, Juhi Kataria, Ravi Kumar Dhawan

BACKGROUND: Both anemia and thyroid disorders are common public health problems with pregnant women being the most vulnerable group. The risk of maternal mortality has a direct correlation with the severity of IDA (Iron Deficiency Anemia). OBJECTIVES: The study aimed to observe the prevalence of anemia and evaluate the level of thyroid hormones in pregnant women and to study their inter-relationship. MATERIALS AND METHODS: A total of 100 antenatal cases of women with the reproductive age group of 20-40 years have been included in the study. Subjects were categorized into three trimesters of pregnancy, viz. first trimester, second trimester and third trimester and their blood samples were analysed for biochemical and hematological parameters. RESULTS: It has been observed that 57% of pregnant women enrolled were anemic with Hb less than 11 g/dl. Based on the haematological studies, the anemic condition was due to the deficiency of iron. Further, thyroid function was found to be correlated with iron deficiency anemia. Subclinical hypothyroidism was found in 49% of anemic subjects. CONCLUSION: Subclinical hypothyroidism is more pronounced effect than overt hypothyroidism due to iron deficiency anemia in pregnancy as revealed from the data generated in the study. Screening of thyroid stimulating hormone in all pregnant women at time of first visit and treatment should be started if TSH <2.5IU/ml for healthy feto-maternal outcome. It has been established from the present study, that anemia can worsen this condition further, since iron deficiency is a major public health problem in developing country like India.

Iron Deficiency AnemiaPregnancyTSHT4T3Body Mass Index.
57,529 views
17,269 downloads

Contributors:

 Gurpreet Kaur Gill
,
 Ankita Ohri
,
 Juhi Kataria
,
 Ravi Kumar Dhawan
Research PaperID: BJMHR1009003

EVALUATE THE EFFICACY , SAFETY AND TOLERABILITY OF ZAVEGEPANT NASAL SPRAY FOR THE ACUTE TREATMENT OF MIGRAINE

Harsh Bansal, isha senthil Velmurugan, nishita gandhi, jeevan jacob, shubham gupta, edla keerthana

Zavegepant is a calcitonin gene related peptide inhibitor which is a new class of drug for acute attack of migraine. It is present in the form of nasal spray for treatment of acute attack of migraine. The objective of study is to evaluate the efficacy , safety and tolerability of this drug for acute attack of migraine. The study was a randomized double blind control trial in which adults (>18 years) with migraine were included in the study. Patients were divided with the help of a web based interactive response system and treated a moderate intensity migraine attack with zavegepant nasal spray 10 mg or placebo. Efficacy was evaluated by relief of symptoms 2 hour after use of nasal spray. 110 patients were randomly divided into 2 groups – group A (57 patients) and group b ( 53 patients). Group A was treated with 10 mg zavegepant nasal spray and group B was given placebo. Group A patients showed the significant relief in symptoms with some showing minor adverse effects such as nausea and crusting in nose. In conclusion zavegepant nasal spray 10 mg is effective for the acute treatment of migraine with good safety profile and tolerability.

Zavegepantmigraine.
57,630 views
17,255 downloads

Contributors:

 Harsh Bansal
,
 isha senthil Velmurugan
,
 nishita gandhi
,
 jeevan jacob
,
 shubham gupta
,
 edla keerthana
Research PaperID: BJMHR1009004

REVIEW ON HYPERTENSIVE EMERGENCY (HTN-E) AND HYPERTENSIVE URGENCY (HTN-U) AS SYSTEMIC ARTERIAL HYPERTENSION (HTN) AND HYPERTENSION-MEDIATED ORGAN DAMAGE (HMOD).

SREEDHAR RANJAN DAS, Dr. Manoj Kumar Pani, Dr. Paresh Mishra ., Mr. Lalatendu Parida ., SANTOSH KUMAR BALA

Objective-To make a review work on Hypertensive emergency (HTN-E) and Hypertensive urgency (HTN-U) as a part of Systemic arterial hypertension (HTN). as the efficiency of medications as well as the patient education and regular treatment. Methods: Various literature reviews are done about Pathophysiology, factors responsible, symptoms, complications, diagnosis, treatment, medications and patient education related with Hypertensive emergency (HTN-E) and Hypertensive urgency (HTN-U) . Results-Hypertensive emergency happens when diastolic pressure greater than 120mm/Hg and occurs end organ damage ,Ischemic heart disease, heart failure, acute chronic syndrome etc. Hypertensive urgency happens when diastolic pressure is greater than 110mm/Hg without any end organ damage but patients have risk factors ; heart disease and renal disease etc. Treatment of (HTN-E) require immediate medical care. The treatment of Hypertensive Urgency is a long term treatment process. In case of pregnancy the B.P should be treated urgently before end organ damage. Patient education for hypertension emergency and urgency is most effective. Conclusion- Prevention is better than cure. So early detection is important. Regular blood pressure checking, and by treatment by both prescribed medication and maintaining healthy life style by balancing the mental stress can control the hypertension .and can be avoided from Hypertension emergency and urgency .So Patient education for hypertension emergency and urgency is most effective.

Hypertensive emergencyHypertensive urgencyPatient education.
57,897 views
17,367 downloads

Contributors:

 SREEDHAR RANJAN DAS
,
 Dr. Manoj Kumar Pani
,
 Dr. Paresh Mishra .
,
 Mr. Lalatendu Parida .
,
 SANTOSH KUMAR BALA